Nasal Drug Delivery Technologies Market By Dosage Form (Sprays, Drops & Liquids, Powders, Gels, Others), Container (Pressurized Containers, Non-pressurized Containers), System (Multi-dose Systems, Bi-dose Systems, Unit-dose Systems), Therapeutic Applications (Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination, Others), Industry Trends, Estimation & Forecast, 2017 - 2025

This report studies Nasal Drug Delivery Technologies in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2025.

Nasal drug delivery technology is the administration of drug through the nasal route. The nasal cavity is an easily accessible route which is generally used for drug delivery. Drugs administered through the nasal route are available in different forms, such as liquid drops, liquid spray, aerosol, suspension spray and gel. The drugs are given in multi dose as well as single dose. Intranasal medicine administration offers a needleless solution to drug delivery. Nasal airway technology is to protect the lungs from harmful contacts, despite acting as a delivery route for drugs.

Market Determinants

Developing acceptance of self-administration practices and growth of over the counter nasal medications are major factors driving the growth of nasal drug delivery market. Moreover, rapid research, development and adoption of new drug delivery technologies and devices, fast onset of action, reformulation of oral drugs and injections into the formulations to be administered by nasal route are also driving the growth of nasal drug delivery market. However, drug formulation failure and technical barrier are restrain the market growth. Additionally, complications created due improper usage of nasal splashes also hamper the market growth. On the other hand, growth among over the counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery, will offer impressive growth opportunities to players operating in this market.

Nasal Drug Delivery Technologies Market Key Segments

o By Dosage Form • Sprays • Drops & Liquids • Powders • Gels • Others o By Container • Pressurized Containers • Non-pressurized Containers o By System • Multi-dose Systems • Bi-dose Systems • Unit-dose Systems o By Therapeutic Applications • Allergic & Non-allergic Rhinitis • Nose Congestion • Vaccination • Others o By End User • Home Care Settings • Hospitals o By Geography o North America
  • U.S.
  • Canada
  • Mexico
o Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
o Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia-Pacific
o Rest of World
  •  Brazil
  •  Saudi Arabia
  •  South Africa
  •  Rest of World

Table of Content

o Novartis AG
o Pfizer Inc.
o AstraZeneca
o AptarGroup, Inc.
o GlaxoSmithKline plc.
o Aegis Therapeutics LLC.
o Becton, Dickinson & Company.
o Johnson & Johnson
o Merck & Co., Inc.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS